GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106. A total of 44 filers reported holding GALMED PHARMACEUTICALS LTD in Q4 2018. The put-call ratio across all filers is 1.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $4,693,000 | -12.1% | 639,269 | -2.2% | 0.31% | +4.3% |
| Q1 2019 | $5,340,000 | +19.6% | 653,590 | -0.0% | 0.30% | +8.3% |
| Q4 2018 | $4,465,000 | -50.1% | 653,667 | -0.0% | 0.28% | -36.7% |
| Q3 2018 | $8,946,000 | +199.1% | 653,957 | +37.3% | 0.44% | +225.4% |
| Q2 2018 | $2,991,000 | +12.8% | 476,190 | 0.0% | 0.13% | -0.7% |
| Q1 2018 | $2,652,000 | -39.1% | 476,190 | 0.0% | 0.14% | -47.1% |
| Q4 2017 | $4,357,000 | – | 476,190 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|